NCT04803721View on ClinicalTrials.gov

Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions
Myelodysplastic Syndromes
Trial Locations (1)

31500

IUCT-Oncopole University Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04803721 - Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes | Biotech Hunter | Biotech Hunter